APA (7th ed.) Citation

Essen, M. R. v., Chow, H. H., Hansen, R. H., Buhelt, S., & Sellebjerg, F. (2023, September). Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control. Frontiers in Immunology.

Chicago Style (17th ed.) Citation

Essen, Marina Rode von, Helene Højsgaard Chow, Rikke Holm Hansen, Sophie Buhelt, and Finn Sellebjerg. "Immune Reconstitution Following Alemtuzumab Therapy Is Characterized by Exhausted T Cells, Increased Regulatory Control of Proinflammatory T Cells and Reduced B Cell Control." Frontiers in Immunology Sep. 2023.

MLA (9th ed.) Citation

Essen, Marina Rode von, et al. "Immune Reconstitution Following Alemtuzumab Therapy Is Characterized by Exhausted T Cells, Increased Regulatory Control of Proinflammatory T Cells and Reduced B Cell Control." Frontiers in Immunology, Sep. 2023.